Trials / Completed
CompletedNCT01079871
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the overall Sjogren's Syndrome subject's preference for a particular product. Dry eye symptom relief will also be evaluated based on clinical evaluation and a set of subject questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FID 114657 (ORB Preserved Ocular Emulsion) | Patients will dose as needed throughout the day (PRN) for 4 weeks. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-06-01
- First posted
- 2010-03-03
- Last updated
- 2012-02-02
Source: ClinicalTrials.gov record NCT01079871. Inclusion in this directory is not an endorsement.